Objectives The study investigated the effect of colistin and minocycline when tested singly
and in combination against Acinetobacter baumannii. Methods Thirteen unrelated imipenem …

Background Extensive drug resistance of Acinetobacter baumannii is a serious problem in
the clinical setting. It is therefore important to find active antibiotic combinations that could be …

The emergence of colistin or tigecycline resistance as well as imipenem resistance in
Acinetobacter baumannii poses a great therapeutic challenge. The bactericidal and …

Objective Nosocomial infection caused by carbapenem-resistant Acinetobacter baumannii is
a worldwide problem and treatment options remain controversial. This study investigated the …

Objectives To determine the in vitro activities and interactions of imipenem, colistin and
tigecycline with old antibacterial agents against carbapenem-resistant Acinetobacter …

Emerging resistance to colistin in clinical Acinetobacter baumannii isolates is of growing
concern. Since current treatment options for these strains are extremely limited, we …

Acinetobacter baumannii is recognized as an urgent public health threat by the Centers for
Disease Control and Prevention (CDC). Current treatment options are scarce, particularly …

Minocycline-based combination therapy has been suggested to be a possible choice for the
treatment of infections caused by minocycline-susceptible Acinetobacter baumannii, but its …

Multidrug-resistant Acinetobacter baumannii infection has presented a global medical
challenge. The antibiograms of paired colistin-susceptible and-resistant strains revealed …

Background This study was designed to verify the effectiveness of antimicrobial combination
therapy against Acinetobacter baumannii isolates with different degrees of resistance to …